论文部分内容阅读
摘要目的从门静脉开放的变化以及临床表现中探讨经皮肝内门体分流术(TIPS)术后的肝硬化和门静脉栓塞病人是否会从抗凝治疗中获益。材料与方法本研究经伦理委员会同意并取得了每例病人的知情同意。2012年11月—2014年2月,经TIPS治疗后的肝硬化和门静脉栓塞病人随
Abstract Objective To investigate whether patients with cirrhosis and portal vein embolization after percutaneous transhepatic portosystemic shunt (TIPS) would benefit from anticoagulant therapy based on the changes of portal venous opening and clinical manifestations. Materials and Methods The study agreed with the Ethics Committee and obtained the informed consent of each patient. From November 2012 to February 2014, patients with cirrhosis and portal vein embolism after TIPS treatment were followed up